clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News & Features
Bioinformatics
Largest Study to Date of COVID-19 Susceptibility Launched
Bioinformatics
Prototype Tool Leverages AI to Predict Which COVID-19 Patients Most Likely…
Precision Medicine
Germline Mutations in Cancer Patients Predict Disease Progression
Oncology
Ovarian Cancer Cells’ Dependence on Fat Suggests New Therapeutic Target
Precision Medicine
COVID-19 Patients May Carry Virus after Symptoms Have Resolved
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Bioinformatics
Largest Study to Date of COVID-19 Susceptibility Launched
Bioinformatics
Prototype Tool Leverages AI to Predict Which COVID-19 Patients Most Likely…
Precision Medicine
Germline Mutations in Cancer Patients Predict Disease Progression
Oncology
Ovarian Cancer Cells’ Dependence on Fat Suggests New Therapeutic Target
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 2
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 5
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 4
Multimedia
All
Webinars
eBooks
eBooks
Clinical Research in a Real-Time Sequencing Age
Precision Medicine
From Bench to Clinic—The Potential of New Sequencing Tools
Precision Medicine
Mainstreaming Precision Oncology
eBooks
Better Understanding of Post-Translation Modifications Driving Innovation
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Molecular Dx
Molecular Diagnostics/In vitro Diagnostics
Molecular Diagnostics/In vitro Diagnostics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Molecular Diagnostics/In vitro Diagnostics
Sophia Genetics, Paragon Genomics Team on SARS-CoV-2 Testing
March 26, 2020
Molecular Diagnostics/In vitro Diagnostics
Crumpled Graphene Improves Detection of DNA Cancer Markers
March 25, 2020
Molecular Diagnostics/In vitro Diagnostics
Novacyt COVID-19 Diagnostic Gains FDA Emergency Use Authorization
March 24, 2020
Molecular Diagnostics/In vitro Diagnostics
IDT’s Fast Scale Up of Kits Primes SARS-CoV-2 Detection
March 13, 2020
Molecular Diagnostics/In vitro Diagnostics
InductiveHealth Launches COVID-19 Analytic Pipeline for Genomic Computing Platform
March 9, 2020
Molecular Diagnostics/In vitro Diagnostics
Thermo Fisher to Acquire QIAGEN for $11.5B
March 3, 2020
Molecular Diagnostics/In vitro Diagnostics
Atrin Pharmaceuticals, Predictive Technology Collaborate to Refine Clinical Trial Recruitment
February 25, 2020
Molecular Diagnostics/In vitro Diagnostics
Liquid Biopsy Developer Karius Completes $165M Series B Financing
February 24, 2020
Molecular Diagnostics/In vitro Diagnostics
Co-Diagnostics Seeks CE Mark for its COVID-19 Coronavirus Test
February 21, 2020
Molecular Diagnostics/In vitro Diagnostics
Agendia Reports Positive Results in IMPACt Trial for Breast Cancer
February 20, 2020
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![One of the major scientific crusades in oncology has been to identify and validate biomarkers associated with recurrent breast cancer. [iStock / royaltystockphoto]](https://www.clinicalomics.com/wp-content/uploads/2019/01/585-324x160.jpeg "Agendia Reports Positive Results in IMPACt Trial for Breast Cancer")
